Get the Stockscreener App
0.3502
0.06%
0.0002
Turnstone Biologics Corp stock is traded at $0.3502, with a volume of 82,535.
It is up +0.06% in the last 24 hours and up +0.03% over the past month.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.
See More
Previous Close:
$0.35
Open:
$0.35
24h Volume:
82,535
Relative Volume:
0.23
Market Cap:
$8.10M
Revenue:
$81.89M
Net Income/Loss:
$-55.20M
P/E Ratio:
-0.1299
EPS:
-2.6959
Net Cash Flow:
$-67.40M
1W Performance:
-2.72%
1M Performance:
+0.03%
6M Performance:
-19.09%
1Y Performance:
-85.65%
1-Day Range:
$0.35
$0.353
1-Week Range:
$0.3455
$0.3598
52-Week Range:
$0.29
$2.47
Turnstone Biologics Corp Stock (TSBX) Company Profile
Name
Turnstone Biologics Corp
Sector
Industry
Phone
347-897-5988
Address
9310 ATHENA CIRCLE, SUITE 300, LA JOLLA
Compare TSBX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TSBX
Turnstone Biologics Corp
|
0.3502 | 8.18M | 81.89M | -55.20M | -67.40M | -2.6959 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Turnstone Biologics Corp Stock (TSBX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-05-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Nov-15-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Oct-14-24 | Downgrade | BofA Securities | Buy → Neutral |
| Aug-16-23 | Initiated | SVB Securities | Market Perform |
| Aug-15-23 | Initiated | BofA Securities | Buy |
| Aug-15-23 | Initiated | Piper Sandler | Overweight |
View All
Turnstone Biologics Corp Stock (TSBX) Latest News
What makes Turnstone Biologics Corp. stock price move sharplyFree Stock Selection With High Accuracy - Newser
What candlestick patterns are forming on Turnstone Biologics Corp.Alpha Trade Flow With Risk Calibration - Newser
Turnstone Biologics Corp. Flashes Rebound Signal in Oversold ConditionDaily Stock Market Swing Alerts Highlight Key Movers - metal.it
What is the dividend policy of Turnstone Biologics Corp. stockAI Powered Picks For Fast Growth - jammulinksnews.com
Is Turnstone Biologics Corp. meeting your algorithmic filter criteriaNeural Network Based Equity Prediction System - Newser
How to read the order book for Turnstone Biologics Corp.Free Risk Controlled Picks With Real Returns - Newser
What is the risk reward ratio of investing in Turnstone Biologics Corp. stockSmart Portfolio Data Feed For 2025 - jammulinksnews.com
How strong is Turnstone Biologics Corp. company’s balance sheetBest Dividend Insights For Fast Growth - jammulinksnews.com
When is the best time to exit Turnstone Biologics Corp.Free Secure Capital Picks With Upside Potential - Newser
New Product Launches: Will They Boost Turnstone Biologics Corp. Stock in 2025 - metal.it
Sectors Driving Future Growth for Turnstone Biologics Corp. StockFree Fundamental + Technical Hybrid Stock Tips - Newser
How did TSBX's revenue and expenses trend in Q4 2024? - AInvest
How Efficient Is Turnstone Biologics Corp. at Controlling Operating CostsFree Trade Timing Strategy With Technical Data - Newser
How to integrate Turnstone Biologics Corp. into portfolio analysis toolsReal-Time AI Entry Forecast Generator - Newser
Why Turnstone Biologics Corp. stock attracts strong analyst attentionHigh Return Strategy with Low Risk - Newser
Published on: 2025-07-28 21:08:16 - metal.it
Is Turnstone Biologics Corp. stock overvalued or undervaluedAchieve rapid wealth accumulation with smart picks - jammulinksnews.com
Intraday pattern recognizer results for Turnstone Biologics Corp.Free Daily Stock Market Swing Alerts - Newser
How many analysts rate Turnstone Biologics Corp. as a “Buy”Breakthrough financial growth - jammulinksnews.com
What institutional investors are buying Turnstone Biologics Corp. stockBuild a winning investment strategy - jammulinksnews.com
Is it the right time to buy Turnstone Biologics Corp. stockRapid growth opportunities - jammulinksnews.com
How does Turnstone Biologics Corp. generate profit in a changing economyFree Market Volatility Navigation Tips - jammulinksnews.com
Published on: 2025-07-28 01:14:26 - jammulinksnews.com
Should I hold or sell Turnstone Biologics Corp. stock in 2025Unlock powerful portfolio management tools - jammulinksnews.com
Does Turnstone Biologics Corp. stock perform well during market downturnsInvest smarter with daily market updates - jammulinksnews.com
Published on: 2025-07-27 23:24:20 - jammulinksnews.com
Key External Factors That Drive Turnstone Biologics Corp. Stock Price MovementsFree Capital Growth Strategies - Newser
Turnstone Biologics Corp. Stock Chart Analysis: Bullish or Bearish Pattern Forming - Newser
Is Turnstone Biologics Corp. Stock a Good Fit for Conservative InvestorsControlled Risk High Reward Plan - Newser
What does TSBX's flat EPS in 2024 suggest for future quarters? - AInvest
What drives Turnstone Biologics Corp. stock priceSpectacular growth rates - PrintWeekIndia
What analysts say about Turnstone Biologics Corp. stockRapidly expanding wealth - PrintWeekIndia
What analysts say about Turnstone Biologics Corp. stock outlookRapid growth trajectories - jammulinksnews.com
Turnstone Biologics Corp Stock (TSBX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):